CUV 1.34% $22.12 clinuvel pharmaceuticals limited


  1. 22,691 Posts.
    The Announcement about PSD included this:

    "Today EpiTan also announced that the volunteer participation aspect of the company’s Phase IIb “sunburn injury” clinical trials with Melanotan concluded in mid-September.

    The data collected from these trials is currently being processed and preliminary results are anticipated in early November".

    So, the trial was completed alright and as I mentioned, they would announce this.

    Now waiting for that Announcement or is it on the web site. Will have a look.

watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Mkt cap $1.045B
Open High Low Value Volume
$22.27 $22.39 $22.05 $158.5K 7.14K

Buyers (Bids)

No. Vol. Price($)
1 50 $22.11

Sellers (Offers)

Price($) Vol. No.
$22.13 33 2
Last update - 11.53am 17/01/2019 (20 minute delay) ?
-0.30 ( 0.97 %)
Open High   Low Volume
$22.25 $22.25   $22.06 1804
Last updated 12.11pm 17/01/2019 (live) ?
CUV (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.